688185.SHG Cansino Biologics Inc

Healthcare Pharmaceuticals Shanghai Stock Exchange
169.49 CNY
Close of Nov 5, 2026
46.89 108.00
Market cap
CNY 19.4B
P/E
490.4x
P/B
3.28x
ROE
0.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 688185.SHG undervalued?

Graham number

The Graham number of Cansino Biologics Inc cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cansino Biologics Inc fundamental analysis

No fundamental analysis for Cansino Biologics Inc yet.

Cansino Biologics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cansino Biologics Inc

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary va…

Full company profile